A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 9/00 (2006.01) A61K 9/127 (2006.01) A61K 31/14 (2006.01) A61K 31/165 (2006.01) A61K 31/216 (2006.01) A61K 31/27 (2006.01) A61K 31/407 (2006.01) A61K 31/4425 (2006.01) A61K 31/473 (2006.01) A61K 31/55 (2006.01) A61K 31/6615 (2006.01) A61K 31/662 (2006.01) A61K 38/38 (2006.01) A61L 31/16 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2514088
There is provided a method of reducing insulin resistance in a mammalian subject comprising administering a suitable acetylcholine esterase antagonist.
La présente invention concerne un procédé permettant la réduction de la résistance à l'insuline chez un mammifère comportant l'administration d'un antagoniste approprié de l'acétylcholine estérase.
Diamedica Inc.
Ridout & Maybee Llp
LandOfFree
Use of cholinesterase antagonists to treat insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cholinesterase antagonists to treat insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cholinesterase antagonists to treat insulin resistance will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1366588